These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1356055)

  • 61. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A remarkable case of thyrotoxicosis initially caused by graves' disease followed by a probable TSHoma - a case report.
    Quinn M; Bashari W; Smith D; Gurnell M; Agha A
    BMC Endocr Disord; 2020 Aug; 20(1):133. PubMed ID: 32854689
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Familial form of thyroid dysgenesis: report of thyroid hemiagenesis with accompanying Graves' disease in a woman whose daughter has thyroid agenesis.
    Lee IT; Sheu WH; Lin SY
    Horm Res; 2003; 59(1):47-9. PubMed ID: 12566736
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunization with thyroglobulin induces Graves'-like disease in mice.
    Endo T; Kobayashi T
    J Endocrinol; 2009 Aug; 202(2):217-22. PubMed ID: 19491147
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Thyroid hemiagenesis associated with Basedow-Graves disease. Report of a case].
    Véliz J; Pineda G
    Rev Med Chil; 2000 Aug; 128(8):896-8. PubMed ID: 11129551
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mean peak systolic velocity of the superior thyroid artery is correlated with radioactive iodine uptake in untreated thyrotoxicosis.
    Chen L; Zhao X; Liu H; Wang Y; Li L; Lu B; Li Y; Hu R
    J Int Med Res; 2012; 40(2):640-7. PubMed ID: 22613425
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake.
    Ikekubo K; Hino M; Ito H; Koh T; Ishihara T; Kurahachi H; Kasagi K; Hidaka A; Mori T
    Ann Nucl Med; 1990 Jul; 4(2):43-8. PubMed ID: 2171608
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical and laboratory assessment of thyroid abnormalities.
    Kaplan MM
    Med Clin North Am; 1985 Sep; 69(5):863-80. PubMed ID: 3903380
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.
    Zuhur SS; Ozel A; Velet S; Buğdacı MS; Cil E; Altuntas Y
    Clinics (Sao Paulo); 2012; 67(2):125-9. PubMed ID: 22358236
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thyroid hemiagenesis with Graves' disease, Graves' ophthalmopathy and multinodular goiter.
    Cakir M; Gonen S; Dikbas O; Ozturk B
    Intern Med; 2009; 48(12):1047-9. PubMed ID: 19525596
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thyroid abnormalities in children of parents who have Graves' disease: possible pre-Graves' disease.
    Carey C; Skosey C; Pinnamaneni KM; Barsano CP; DeGroot LJ
    Metabolism; 1980 Apr; 29(4):369-76. PubMed ID: 6892833
    [No Abstract]   [Full Text] [Related]  

  • 73. The utility of thyroid nuclear imaging and other studies in the detection and treatment of underlying thyroid abnormalities in patients with endogenous subclinical thyrotoxicosis.
    Tollin SR; Fallon EF; Mikhail M; Goldstein H; Yung E
    Clin Nucl Med; 2000 May; 25(5):341-7. PubMed ID: 10795691
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Subacute thyroiditis with cell destruction and temporary hyperthyroidism in Graves'disease--case report].
    Pichler R; Wölfl S; Bogner S; Sulzbacher H; Shamiyeh A; Maschek W
    Acta Med Austriaca; 2002; 29(4):137-40. PubMed ID: 12424939
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of thyroid Doppler in differential diagnosis of thyrotoxicosis.
    Hari Kumar KV; Pasupuleti V; Jayaraman M; Abhyuday V; Rayudu B R; Modi KD
    Endocr Pract; 2009; 15(1):6-9. PubMed ID: 19211390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Neonatal hyperthyroidism secondary to Basedow's disease in the mother].
    Mouroux D; Martin Laval A; Bovero G; Nicolino J
    Presse Med; 1991 Feb; 20(4):167-70. PubMed ID: 1672233
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis.
    Meringolo D; Campi I; Costante G
    Endocrine; 2018 Nov; 62(2):490-491. PubMed ID: 29987702
    [No Abstract]   [Full Text] [Related]  

  • 78. Thyroid stimulating immunoglobulin is often negative in children with Graves' disease.
    Rahhal SN; Eugster EA
    J Pediatr Endocrinol Metab; 2008 Nov; 21(11):1085-8. PubMed ID: 19189704
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A case report of 131I therapy for Graves' disease patient with hemiagenesis.
    Liu X; Zhang J; Meng Z; Yu H; Gao Z; Li H; Liu N
    Medicine (Baltimore); 2019 Feb; 98(8):e14606. PubMed ID: 30813185
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Developmental delay and failure to thrive in a 7-month-old baby boy with spontaneous transient Graves' thyrotoxicosis: a case report.
    Yatsuga S; Saikusa T; Sasaki T; Ushijima K; Kitamura M; Nishioka J; Koga Y
    J Med Case Rep; 2016 Aug; 10(1):219. PubMed ID: 27510038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.